Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases

W.M. de Vos (Inventor)

Research output: PatentOther research output

Abstract

The invention is concerned with a novel human intestinal isolate capable of converting L- lysine into butyrate and/or of converting fructose-lysine into butyrate. The novel isolate can be used as a probiotic or supplement to promote production of butyrate in the Gl tract, thereby preventing and/or treating conditions or diseases that benefit from the production of butyrate. Additionally, the isolate may prevent and/or treat conditions or diseases caused by an excess of pathogenic bacteria in the Gl tract, mediated by L-lysine, or mediated by fructose-lysine or other advanced glycation end products.
Original languageEnglish
Patent numberWO2016110585
Priority date9/01/15
Publication statusPublished - 14 Jul 2016

Fingerprint

Butyrates
Lysine
Bacteria
Advanced Glycosylation End Products
Probiotics
lysine butyrate
fructosyl-lysine

Cite this

@misc{c1f04de0ae0a4f9294111071a6df457f,
title = "Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases",
abstract = "The invention is concerned with a novel human intestinal isolate capable of converting L- lysine into butyrate and/or of converting fructose-lysine into butyrate. The novel isolate can be used as a probiotic or supplement to promote production of butyrate in the Gl tract, thereby preventing and/or treating conditions or diseases that benefit from the production of butyrate. Additionally, the isolate may prevent and/or treat conditions or diseases caused by an excess of pathogenic bacteria in the Gl tract, mediated by L-lysine, or mediated by fructose-lysine or other advanced glycation end products.",
author = "{de Vos}, W.M.",
year = "2016",
month = "7",
day = "14",
language = "English",
type = "Patent",
note = "WO2016110585",

}

TY - PAT

T1 - Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases

AU - de Vos, W.M.

PY - 2016/7/14

Y1 - 2016/7/14

N2 - The invention is concerned with a novel human intestinal isolate capable of converting L- lysine into butyrate and/or of converting fructose-lysine into butyrate. The novel isolate can be used as a probiotic or supplement to promote production of butyrate in the Gl tract, thereby preventing and/or treating conditions or diseases that benefit from the production of butyrate. Additionally, the isolate may prevent and/or treat conditions or diseases caused by an excess of pathogenic bacteria in the Gl tract, mediated by L-lysine, or mediated by fructose-lysine or other advanced glycation end products.

AB - The invention is concerned with a novel human intestinal isolate capable of converting L- lysine into butyrate and/or of converting fructose-lysine into butyrate. The novel isolate can be used as a probiotic or supplement to promote production of butyrate in the Gl tract, thereby preventing and/or treating conditions or diseases that benefit from the production of butyrate. Additionally, the isolate may prevent and/or treat conditions or diseases caused by an excess of pathogenic bacteria in the Gl tract, mediated by L-lysine, or mediated by fructose-lysine or other advanced glycation end products.

M3 - Patent

M1 - WO2016110585

ER -